| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2021 | VIRSCIO, INC | 4 SCIENCE PARK STE 4 | NEW HAVEN | CT | 06511-1962 | SOUTH CENTRAL CT | USA | R44AG067832 | Amyloid Beta Oligomer Induction of Alzheimer Disease in Nonhuman Primates | 000 | 3 | NIH | 11/1/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2021 | VIRSCIO INC | 4 SCIENCE PARK | NEW HAVEN | CT | 06511-1962 | SOUTH CENTRAL CT | USA | R44AG067832 | Amyloid Beta Oligomer Induction of Alzheimer Disease in Nonhuman Primates | 000 | 3 | NIH | 9/19/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2021 | VIRSCIO INC | 4 SCIENCE PARK | NEW HAVEN | CT | 06511-1962 | SOUTH CENTRAL CT | USA | R44AG067832 | Amyloid Beta Oligomer Induction of Alzheimer Disease in Nonhuman Primates | 000 | 3 | NIH | 4/4/2022 | $0 |
| | 2022 | 2021 | VIRSCIO INC | 4 SCIENCE PARK | NEW HAVEN | CT | 06511-1962 | SOUTH CENTRAL CT | USA | R44AG067832 | Amyloid Beta Oligomer Induction of Alzheimer Disease in Nonhuman Primates | 001 | 3 | NIH | 6/15/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $770,793 ) |
| | 2021 | 2021 | VIRSCIO, INC. | 4 SCIENCE PARK | NEW HAVEN | CT | 06511-1962 | SOUTH CENTRAL CT | USA | R44AG067832 | Amyloid Beta Oligomer Induction of Alzheimer Disease in Nonhuman Primates | 002 | 3 | NIH | 8/25/2021 | $770,793 |
| | 2021 | 2020 | VIRSCIO, INC. | 4 SCIENCE PARK | NEW HAVEN | CT | 06511-1962 | SOUTH CENTRAL CT | USA | R44AG067832 | Amyloid Beta Oligomer Induction of Alzheimer Disease in Nonhuman Primates | 000 | 2 | NIH | 11/18/2020 | $0 |
| | 2021 | 2020 | VIRSCIO, INC. | 4 SCIENCE PARK | NEW HAVEN | CT | 06511-1962 | SOUTH CENTRAL CT | USA | R44AG067832 | Amyloid Beta Oligomer Induction of Alzheimer Disease in Nonhuman Primates | 001 | 2 | NIH | 5/25/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,119,343 ) |
| | 2020 | 2020 | VIRSCIO, INC. | 4 SCIENCE PARK | NEW HAVEN | CT | 06511-1962 | SOUTH CENTRAL CT | USA | R44AG067832 | Amyloid Beta Oligomer Induction of Alzheimer Disease in Nonhuman Primates | 000 | 2 | NIH | 8/28/2020 | $1,119,343 |
| | 2020 | 2018 | VIRSCIO, INC. | 4 SCIENCE PARK | NEW HAVEN | CT | 06511-1962 | SOUTH CENTRAL CT | USA | R43OD023025 | Amyloid Beta Oligomer Induction of Alzheimer's Disease in Nonhuman Primates | 001 | 1 | NIH | 12/21/2019 | $0 |
| | 2020 | 2017 | VIRSCIO, INC. | 4 SCIENCE PARK | NEW HAVEN | CT | 06511-1962 | SOUTH CENTRAL CT | USA | R43OD023025 | Amyloid Beta Oligomer Induction of Alzheimer's Disease in Nonhuman Primates | 000 | 1 | NIH | 12/4/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $49,018 ) |
| | 2018 | 2018 | RXGEN INC | 100 DEEPWOOD DR | HAMDEN | CT | 06517-3452 | SOUTH CENTRAL CT | USA | R43OD023025 | Amyloid Beta Oligomer Induction of Alzheimer's Disease in Nonhuman Primates | 000 | 1 | NIH | 9/19/2018 | $49,018 |
|
| Issue Date FY: 2017 ( Subtotal = $208,201 ) |
| | 2017 | 2017 | RXGEN INC | 100 DEEPWOOD DR | HAMDEN | CT | 06517-3452 | SOUTH CENTRAL CT | USA | R43OD023025 | Amyloid Beta Oligomer Induction of Alzheimer's Disease in Nonhuman Primates | 000 | 1 | NIH | 9/6/2017 | $208,412 |
| | 2017 | 2013 | RXGEN INC | 100 DEEPWOOD DR | HAMDEN | CT | 06517-3452 | SOUTH CENTRAL CT | USA | R43EY023867 | Establishing a neuroprotection model in the nonhuman primate to support translati | 000 | 1 | NIH | 5/17/2017 | -$211 |
|
| Issue Date FY: 2013 ( Subtotal = $203,038 ) |
| | 2013 | 2013 | RX GEN INC | 100 DEEPWOOD DRIVE | HAMDEN | CT | 06517-3452 | SOUTH CENTRAL CT | USA | R43EY023867 | Establishing a neuroprotection model in the nonhuman primate to support translati | 000 | 1 | NIH | 9/19/2013 | $203,038 |
|
| Issue Date FY: 2011 ( Subtotal = $718,304 ) |
| | 2011 | 2011 | RX GEN INC | 100 DEEPWOOD DRIVE | HAMDEN | CT | 06517-3452 | SOUTH CENTRAL CT | USA | R43HL110514 | SILENCING CARDIAC-SPECIFIC MICRORNAS TO PREVENT PATHOLOGICAL REMODELING IN CONGES | 000 | 1 | NIH | 8/22/2011 | $718,304 |
|
| Issue Date FY: 2009 ( Subtotal = $668,381 ) |
| | 2009 | 2009 | RX GEN INC | 100 DEEPWOOD DRIVE | HAMDEN | CT | 06517-3452 | SOUTH CENTRAL CT | USA | R44NS054410 | ULTRASOUND-MEDIATED BLOOD-BRAIN BARRIER PERMEABILIZATION IN PRIMATES | 000 | 3 | NIH | 6/10/2009 | $668,381 |
|
| Issue Date FY: 2008 ( Subtotal = $694,061 ) |
| | 2008 | 2008 | RX GEN INC | 100 DEEPWOOD DRIVE | HAMDEN | CT | 06517 | SOUTH CENTRAL CT | USA | R44NS054410 | ULTRASOUND-MEDIATED BLOOD-BRAIN BARRIER PERMEABILIZATION IN PRIMATES | 000 | 2 | NIH | 6/11/2008 | $694,061 |
|
| Issue Date FY: 2006 ( Subtotal = $999,831 ) |
| | 2006 | 2006 | RX GEN INC | 100 DEEPWOOD DRIVE | HAMDEN | CT | 06517 | SOUTH CENTRAL CT | USA | R43NS054410 | ULTRASOUND-MEDIATED BLOOD-BRAIN BARRIER PERMEABILIZATION IN PRIMATES | 000 | 1 | NIH | 5/2/2006 | $208,554 |
| | 2006 | 2006 | RX GEN INC | 100 DEEPWOOD DRIVE | HAMDEN | CT | 06517 | SOUTH CENTRAL CT | USA | R44DK066955 | TOXICOGENOMICS OF HEPATOTOXICITY IN MONKEYS | 001 | 3 | NIH | 7/28/2006 | $55,000 |
| | 2006 | 2006 | RX GEN INC | 100 DEEPWOOD DRIVE | HAMDEN | CT | 06517 | SOUTH CENTRAL CT | USA | R44DK066955 | TOXICOGENOMICS OF HEPATOTOXICITY IN MONKEYS | 000 | 3 | NIH | 7/24/2006 | $736,277 |
|
| Issue Date FY: 2005 ( Subtotal = $512,528 ) |
| | 2005 | 2005 | RX GEN INC | 100 DEEPWOOD DRIVE | HAMDEN | CT | 06517 | SOUTH CENTRAL CT | USA | R44DK066955 | TOXICOGENOMICS OF HEPATOTOXICITY IN MONKEYS | 000 | 2 | NIH | 9/23/2005 | $512,528 |
|
| Issue Date FY: 2004 ( Subtotal = $476,886 ) |
| | 2004 | 2004 | RX GEN INC | 100 DEEPWOOD DRIVE | HAMDEN | CT | 06517 | SOUTH CENTRAL CT | USA | R44DK066955 | TOXICOGENOMICS OF HEPATOTOXICITY IN MONKEYS | 000 | 1 | NIH | 8/12/2004 | $249,123 |
| | 2004 | 2004 | RX GEN INC | 100 DEEPWOOD DRIVE | HAMDEN | CT | 06517 | SOUTH CENTRAL CT | USA | R43NS048786 | GENOMIC MARKERS OF ENVIRONMENTAL TOXINS FOR PARKINSONISM | 000 | 1 | NIH | 8/25/2004 | $227,763 |
|
|
